These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1387425)

  • 41. [An evaluation of the therapeutic trials aimed at regression of ventricular hypertrophy in arterial hypertension].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Ann Cardiol Angeiol (Paris); 1991 Oct; 40(8):503-8. PubMed ID: 1836942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Remission of hypertension in Nigerians. Clinical observations in twelve patients.
    Carlisle R
    Afr J Med Sci; 1971 Jan; 2(1):57-63. PubMed ID: 4255484
    [No Abstract]   [Full Text] [Related]  

  • 43. [Arrhythmia in hypertension].
    Takeda K; Sasaki S; Nakagawa M
    Nihon Rinsho; 1992 Apr; 50 Suppl():608-14. PubMed ID: 1386127
    [No Abstract]   [Full Text] [Related]  

  • 44. Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program.
    Borhani NO; Blaufox MD; Oberman A; Polk BF
    Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):55-62. PubMed ID: 2947267
    [No Abstract]   [Full Text] [Related]  

  • 45. Ventricular arrhythmias and left ventricular hypertrophy secondary to hypertension: a brief review.
    McLenachan JM; Dargie HJ
    Scand J Clin Lab Invest Suppl; 1989; 196():28-32. PubMed ID: 2530619
    [No Abstract]   [Full Text] [Related]  

  • 46. [Ventricular arrhythmia in patients with hypertension and left ventricular hypertrophy].
    Sami MH
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():59-62. PubMed ID: 2150475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of left ventricular hypertrophy: a desirable therapeutic goal?
    Schmieder RE; Messerli FH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S16-22. PubMed ID: 1707110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E; Muiesan ML
    Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cardiac changes in the obese, as a function of disorders of glycoregulation].
    Fekete T; Constantin C
    Med Interna (Bucur); 1974 May; 26(5):577-82. PubMed ID: 4276427
    [No Abstract]   [Full Text] [Related]  

  • 51. Left ventricular hypertrophy in hypertension and the effects of antihypertensive drug therapy.
    Hachamovitch R; Sonnenblick EH; Strom JA; Frishman WH
    Curr Probl Cardiol; 1988 Jun; 13(6):375-421. PubMed ID: 2978689
    [No Abstract]   [Full Text] [Related]  

  • 52. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [What is safe in the therapy of hypertensive heart disease?].
    Motz W; Strauer BE
    Internist (Berl); 1985 Dec; 26(12):750-64. PubMed ID: 2867983
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cardiovascular complications in hypertension].
    Wójtowska E; Przybył L; Urbański K
    Wiad Lek; 1981 Oct; 34(19):1591-4. PubMed ID: 7336721
    [No Abstract]   [Full Text] [Related]  

  • 55. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A symposium: Arterial hypertension--cardiac hypertrophy and failure. June 8-10, 1989, Düsseldorf. Proceedings.
    Am J Cardiol; 1990 Apr; 65(14):1G-88G. PubMed ID: 2138852
    [No Abstract]   [Full Text] [Related]  

  • 57. Beyond blood pressure control. Effect of antihypertensive therapy on cardiovascular risk factors.
    Maxwell MH
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):366S-371S. PubMed ID: 3056446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Left ventricular hypertrophy. A crucial target for antihypertensive therapy.
    Messerli FH
    Postgrad Med; 1990 Jul; 88(1):127-8, 131, 134. PubMed ID: 2142278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Echocardiographic left ventricular hypertrophy in hypertension.
    Drayer JI; Gardin JM; Weber MA
    Chest; 1983 Aug; 84(2):217-21. PubMed ID: 6223791
    [No Abstract]   [Full Text] [Related]  

  • 60. 'Silent ischemia,' ventricular arrhythmias, and complications of hypertension.
    Devereux RB
    Circulation; 1992 May; 85(5):1948-50. PubMed ID: 1533353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.